Self-Regulatory Organizations; NYSE Arca, Inc.; Order Approving Proposed Rule Change Relating to Listing Certain Derivative Products Pursuant to Continued Listing Criteria, 71073-71074 [E8-27878]
Download as PDF
Federal Register / Vol. 73, No. 227 / Monday, November 24, 2008 / Notices
Without this filing, orders in FCOs that
access the Exchange via Linkage will be
charged more than similar electronic
transactions on the Exchange.
B. Self-Regulatory Organization’s
Statement on Burden on Competition
The Exchange does not believe that
the proposed rule change will impose
any burden on competition that is not
necessary or appropriate in furtherance
of the purposes of the Act.
C. Self-Regulatory Organization’s
Statement on Comments on the
Proposed Rule Change Received From
Members, Participants or Others
No written comments were solicited
or received with respect to the proposed
rule change.
III. Date of Effectiveness of the
Proposed Rule Change and Timing for
Commission Action
Within 35 days of the date of
publication of this notice in the Federal
Register or within such longer period (i)
as the Commission may designate up to
90 days of such date if it finds such
longer period to be appropriate and
publishes its reasons for so finding or
(ii) as to which the Exchange consents,
the Commission will:
(A) By order approve the proposed
rule change, or
(B) Institute proceedings to determine
whether the proposed rule change
should be disapproved.
post all comments on the Commission’s
Internet Web site (https://www.sec.gov/
rules/sro.shtml). Copies of the
submission, all subsequent
amendments, all written statements
with respect to the proposed rule
change that are filed with the
Commission, and all written
communications relating to the
proposed rule change between the
Commission and any person, other than
those that may be withheld from the
public in accordance with the
provisions of 5 U.S.C. 552, will be
available for inspection and copying in
the Commission’s Public Reference
Room, on official business days between
the hours of 10 a.m. and 3 p.m. Copies
of such filing also will be available for
inspection and copying at the principal
office of the Exchange. All comments
received will be posted without change;
the Commission does not edit personal
identifying information from
submissions. You should submit only
information that you wish to make
available publicly. All submissions
should refer to File Number SR–
NYSEArca–2008–118 and should be
submitted on or before December 15,
2008.
For the Commission, by the Division of
Trading and Markets, pursuant to delegated
authority.7
Florence E. Harmon,
Acting Secretary.
[FR Doc. E8–27877 Filed 11–21–08; 8:45 am]
BILLING CODE 8011–01–P
IV. Solicitation of Comments
Interested persons are invited to
submit written data, views, and
arguments concerning the foregoing,
including whether the proposed rule
change is consistent with the Act.
Comments may be submitted by any of
the following methods:
SECURITIES AND EXCHANGE
COMMISSION
[Release No. 34–58948; File No. SR–
NYSEArca–2008–105]
Electronic Comments
• Use the Commission’s Internet
comment form (https://www.sec.gov/
rules/sro.shtml); or
• Send an e-mail to rulecomments@sec.gov. Please include File
No. SR–NYSEArca–2008–118 on the
subject line.
Self-Regulatory Organizations; NYSE
Arca, Inc.; Order Approving Proposed
Rule Change Relating to Listing
Certain Derivative Products Pursuant
to Continued Listing Criteria
November 14, 2008.
sroberts on PROD1PC70 with NOTICES
Paper Comments
• Send paper comments in triplicate
to Secretary, Securities and Exchange
Commission, Station Place, 100 F Street,
NE., Washington, DC 20549–1090.
All submissions should refer to File
Number SR–NYSEArca–2008–118. This
file number should be included on the
subject line if e-mail is used. To help the
Commission process and review your
comments more efficiently, please use
only one method. The Commission will
VerDate Aug<31>2005
19:32 Nov 21, 2008
Jkt 217001
I. Introduction
On October 1, 2008, NYSE Arca, Inc.
(‘‘Exchange’’ or ‘‘NYSE Arca’’), through
its wholly owned subsidiary, NYSE
Arca Equities, Inc. (‘‘NYSE Arca
Equities’’), filed with the Securities and
Exchange Commission (‘‘Commission’’)
pursuant to Section 19(b)(1) of the
Securities Exchange Act of 1934
(‘‘Act’’) 1 and Rule 19b–4 thereunder,2 a
proposed rule change relating to listing
certain Derivative Products (as defined
7 17
CFR 200.30–3(a)(12).
U.S.C. 78s(b)(1).
2 17 CFR 240.19b–4.
1 15
PO 00000
Frm 00121
Fmt 4703
Sfmt 4703
71073
in proposed Commentary .01 to NYSE
Arca Equities Rule 5.2(b)) pursuant to
continued listing criteria. The proposed
rule change was published for comment
in the Federal Register on October 10,
2008.3 The Commission received no
comment letters on the proposed rule
change. This order approves the
proposed rule change.
II. Description of the Proposed Rule
Change
The Exchange proposes to adopt new
Commentary .01 to NYSE Arca Equities
Rule 5.2(b) to permit the listing of a
Derivative Product 4 that (1) was
originally listed on another registered
national securities exchange (‘‘Other
SRO’’) and continues to be listed on
such Other SRO, and (2) satisfies the
Exchange’s continued listing criteria
applicable to the relevant product class
that would include such Derivative
Product.
For example, in the case of an IndexLinked Security that is listed on an
Other SRO, the staff of the Exchange
would determine whether the IndexLinked Security meets the Exchange’s
continued listing criteria. If the IndexLinked Security satisfies the Exchange’s
continued listing criteria, then NYSE
Arca could proceed to list such security
on the Exchange. If the Index-Linked
Security does not meet the continued
listing criteria, the staff of the Exchange
would then, in its sole discretion, either
file a separate rule filing pursuant to
Rule 19b–4 under the Act proposing
that the Index-Linked Security be listed
on the Exchange pursuant to the criteria
3 See Securities Exchange Act Release No. 58734
(October 6, 2008), 73 FR 60388.
4 Commentary .01 to NYSE Arca Equities Rule
5.2(b) defines ‘‘Derivative Product’’ to include
securities described in NYSE Arca Equities Rule
5.2(j)(2) (Equity Linked Notes); NYSE Arca Equities
Rule 5.2(j)(3) (Investment Company Units); NYSE
Arca Equities Rule 5.2(j)(4) (Index-Linked
Exchangeable Notes); NYSE Arca Equities Rule
5.2(j)(6) (Equity Index-Linked Securities,
Commodity-Linked Securities, Currency-Linked
Securities, Fixed Income Index-Linked Securities,
Futures-Linked Securities, and Multifactor IndexLinked Securities); NYSE Arca Equities Rule 8.100
(Portfolio Depositary Receipts); and Commentary
.01 to NYSE Arca Equities Rule 8.200 (Trust Issued
Receipts). Exchange rules relating to the listing and
trading, including trading pursuant to unlisted
trading privileges, of ‘‘Derivative Products,’’ as
described above, permit the listing and trading of
such products pursuant to Rule 19b–4(e) under the
Act. Rule 19b–4(e) under the Act provides that the
listing and trading of a new derivative securities
product by a self-regulatory organization (‘‘SRO’’)
shall not be deemed a proposed rule change,
pursuant to paragraph (c)(1) of Rule 19b–4, if the
Commission has approved, pursuant to Section
19(b) of the Act, the SRO’s trading rules,
procedures, and listing standards for the product
class that would include the new derivatives
securities product, and the SRO has a surveillance
program for the product class. See 17 CFR 240.19b–
4(e)(1).
E:\FR\FM\24NON1.SGM
24NON1
71074
Federal Register / Vol. 73, No. 227 / Monday, November 24, 2008 / Notices
set forth in the rule filing or decline to
list the Index-Linked Security on the
Exchange.
Prior to listing on the Exchange, the
issuer of a Derivative Product would be
required to properly delist from the
Other SRO and satisfy the applicable
listing procedures of the Exchange and
applicable statutory and regulatory
requirements, including, without
limitation, Section 12 of the Act,5
relating to listing such Derivative
Product on the Exchange. In addition,
the Exchange represents that, for any
Derivative Product listed pursuant to
proposed Commentary .01 to NYSE
Arca Equities Rule 5.2(b), other than the
initial listing standards, the shares or
other units of such Derivative Product
will comply with all other pertinent
requirements applicable to the product
class that would include such
Derivative Product, including, but not
limited to, requirements relating to the
dissemination of key information, such
as an index value, reference asset value,
and intraday indicative value, and rules
governing the trading of equity
securities, trading hours, trading halts,
surveillance, firewalls, and Information
Bulletins to ETP Holders, as set forth in
Exchange rules applicable to such
Derivative Product and prior
Commission orders approving the
generic listing rules applicable to the
listing and trading of such Derivative
Product.
sroberts on PROD1PC70 with NOTICES
III. Discussion and Commission’s
Findings
The Commission has carefully
reviewed the proposed rule change and
finds that it is consistent with the
requirements of Section 6 of the Act 6
and the rules and regulations
thereunder applicable to a national
securities exchange.7 In particular, the
Commission finds that the proposed
rule change is consistent with Section
6(b)(5) of the Act,8 which requires,
among other things, that the Exchange’s
rules be designed to promote just and
equitable principles of trade, to remove
impediments to and perfect the
mechanism of a free and open market
and a national market system, and, in
general, to protect investors and the
public interest.
The proposal would permit the
Exchange to list and trade any
Derivative Product that (1) was
originally listed on an Other SRO and
5 15
U.S.C. 78(l).
U.S.C. 78f.
7 In approving this proposed rule change, the
Commission has considered the proposed rule’s
impact on efficiency, competition, and capital
formation. See 15 U.S.C. 78c(f).
8 15 U.S.C. 78f(b)(5).
6 15
VerDate Aug<31>2005
19:32 Nov 21, 2008
Jkt 217001
continues to be listed on such Other
SRO, and (2) satisfies the Exchange’s
continued listing criteria applicable to
the product class that would include
such Derivative Product. The
Commission believes that the proposal
reasonably balances the removal of
impediments to a free and open market
with the protection of investors and the
public interest, two principles set forth
in Section 6(b)(5) of the Act. The
Commission notes that (1) it has
previously approved the generic listing
standards, including the continued
listing criteria, applicable to each
product class that would include such
Derivative Product, and (2) the
continued listing criteria applicable to a
Derivative Product are substantially
similar to those of Other SROs that list
such Derivative Product.9 The
Commission also notes that, for any
Derivative Product listed on the
Exchange pursuant to proposed
Commentary .01 to NYSE Arca Equities
Rule 5.2(b), the shares of such
Derivative Product must comply with
all of the other pertinent requirements
applicable to the product class that
would include such Derivative Product
including, without limitation,
requirements relating to the
dissemination of key values and the
rules governing the trading of equity
securities, trading hours, trading halts,
surveillance, firewalls, and Information
Bulletins to ETP Holders, as set forth in
the applicable Exchange rules and prior
Commission orders approving the
generic listing rules applicable to the
listing and trading of such Derivative
Product. In addition, prior to listing on
the Exchange, the issuer of a Derivative
Product must properly delist from the
Other SRO and satisfy all relevant
Exchange listing procedures and
applicable statutory and regulatory
requirements, including, without
limitation, Section 12 of the Act. If the
Exchange seeks to list a Derivative
Product that does not satisfy the
Exchange’s continued listing standards
applicable to such product, it may not
do so pursuant to proposed
Commentary .01 to NYSE Arca Equities
9 For example, the following are NYSE Alternext
US LLC (‘‘NYSE Alternext’’) listing standards for
Derivative Products having similar or identical
continued listing standards to those of the
Exchange: Index Fund Shares (NYSE Alternext
Equities Rule 1000A et seq.); Portfolio Depositary
Receipts (Rules 1000 et seq.); Trust Issued Receipts
(Rules 1200 et seq.); and securities listed under
Section 107 of the NYSE Alternext Company Guide,
including Equity-Linked Term Notes; Index-Linked
Exchangeable Notes; Index-Linked Securities;
Commodity-Linked Securities; Currency-Linked
Securities; Fixed Income-Linked Securities;
Futures-Linked Securities; and Combination-Linked
Securities.
PO 00000
Frm 00122
Fmt 4703
Sfmt 4703
Rule 5.2(b). Instead, the Exchange must
obtain prior Commission approval
pursuant to Section 19(b)(2) of the Act.
The Commission believes that the
Exchange’s proposal would facilitate the
timely and efficient listing and
continuous trading of a Derivative
Product should an issuer of such
Derivative Product, originally listed on
an Other SRO, choose to delist from
such Other SRO and list such Derivative
Product on the Exchange, provided that
all of the requirements with respect to
the Derivative Product referenced
herein, including all of the applicable
requirements governing the trading of
such Derivative Product, as set forth in
Exchange rules and prior applicable
Commission orders, are satisfied. For
the foregoing reasons, the Commission
believes that the proposed rule change
is consistent with the Act and finds
good cause for approving the proposed
rule change.
IV. Conclusion
It is therefore ordered, pursuant to
Section 19(b)(2) of the Act,10 that the
proposed rule change (SR–NYSEArca–
2008–105) be, and it hereby is,
approved.
For the Commission, by the Division of
Trading and Markets, pursuant to delegated
authority.11
Florence E. Harmon,
Acting Secretary.
[FR Doc. E8–27878 Filed 11–21–08; 8:45 am]
BILLING CODE 8011–01–P
SECURITIES AND EXCHANGE
COMMISSION
[Release No. 34–58956; File No. SR–
NYSEArca–2008–124]
Self-Regulatory Organizations; NYSE
Arca, Inc.; Notice of Filing and Order
Granting Accelerated Approval of
Proposed Rule Change To List Shares
of iShares Silver Trust
November 14, 2008.
Pursuant to Section 19(b)(1) of the
Securities Exchange Act of 1934
(‘‘Act’’) 1 and Rule 19b–4 thereunder,2
notice is hereby given that, on
November 5, 2008, NYSE Arca, Inc.
(‘‘NYSE Arca’’ or ‘‘Exchange’’) filed
with the Securities and Exchange
Commission (‘‘Commission’’) the
proposed rule change as described in
Items I and II below, which Items have
been prepared by the Exchange. The
Commission is publishing this notice to
10 15
U.S.C. 78s(b)(1).
CFR 200.30–3(a)(12).
1 15 U.S.C. 78s(b)(1).
2 17 CFR 240.19b–4.
11 17
E:\FR\FM\24NON1.SGM
24NON1
Agencies
[Federal Register Volume 73, Number 227 (Monday, November 24, 2008)]
[Notices]
[Pages 71073-71074]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: E8-27878]
-----------------------------------------------------------------------
SECURITIES AND EXCHANGE COMMISSION
[Release No. 34-58948; File No. SR-NYSEArca-2008-105]
Self-Regulatory Organizations; NYSE Arca, Inc.; Order Approving
Proposed Rule Change Relating to Listing Certain Derivative Products
Pursuant to Continued Listing Criteria
November 14, 2008.
I. Introduction
On October 1, 2008, NYSE Arca, Inc. (``Exchange'' or ``NYSE
Arca''), through its wholly owned subsidiary, NYSE Arca Equities, Inc.
(``NYSE Arca Equities''), filed with the Securities and Exchange
Commission (``Commission'') pursuant to Section 19(b)(1) of the
Securities Exchange Act of 1934 (``Act'') \1\ and Rule 19b-4
thereunder,\2\ a proposed rule change relating to listing certain
Derivative Products (as defined in proposed Commentary .01 to NYSE Arca
Equities Rule 5.2(b)) pursuant to continued listing criteria. The
proposed rule change was published for comment in the Federal Register
on October 10, 2008.\3\ The Commission received no comment letters on
the proposed rule change. This order approves the proposed rule change.
---------------------------------------------------------------------------
\1\ 15 U.S.C. 78s(b)(1).
\2\ 17 CFR 240.19b-4.
\3\ See Securities Exchange Act Release No. 58734 (October 6,
2008), 73 FR 60388.
---------------------------------------------------------------------------
II. Description of the Proposed Rule Change
The Exchange proposes to adopt new Commentary .01 to NYSE Arca
Equities Rule 5.2(b) to permit the listing of a Derivative Product \4\
that (1) was originally listed on another registered national
securities exchange (``Other SRO'') and continues to be listed on such
Other SRO, and (2) satisfies the Exchange's continued listing criteria
applicable to the relevant product class that would include such
Derivative Product.
---------------------------------------------------------------------------
\4\ Commentary .01 to NYSE Arca Equities Rule 5.2(b) defines
``Derivative Product'' to include securities described in NYSE Arca
Equities Rule 5.2(j)(2) (Equity Linked Notes); NYSE Arca Equities
Rule 5.2(j)(3) (Investment Company Units); NYSE Arca Equities Rule
5.2(j)(4) (Index-Linked Exchangeable Notes); NYSE Arca Equities Rule
5.2(j)(6) (Equity Index-Linked Securities, Commodity-Linked
Securities, Currency-Linked Securities, Fixed Income Index-Linked
Securities, Futures-Linked Securities, and Multifactor Index-Linked
Securities); NYSE Arca Equities Rule 8.100 (Portfolio Depositary
Receipts); and Commentary .01 to NYSE Arca Equities Rule 8.200
(Trust Issued Receipts). Exchange rules relating to the listing and
trading, including trading pursuant to unlisted trading privileges,
of ``Derivative Products,'' as described above, permit the listing
and trading of such products pursuant to Rule 19b-4(e) under the
Act. Rule 19b-4(e) under the Act provides that the listing and
trading of a new derivative securities product by a self-regulatory
organization (``SRO'') shall not be deemed a proposed rule change,
pursuant to paragraph (c)(1) of Rule 19b-4, if the Commission has
approved, pursuant to Section 19(b) of the Act, the SRO's trading
rules, procedures, and listing standards for the product class that
would include the new derivatives securities product, and the SRO
has a surveillance program for the product class. See 17 CFR
240.19b-4(e)(1).
---------------------------------------------------------------------------
For example, in the case of an Index-Linked Security that is listed
on an Other SRO, the staff of the Exchange would determine whether the
Index-Linked Security meets the Exchange's continued listing criteria.
If the Index-Linked Security satisfies the Exchange's continued listing
criteria, then NYSE Arca could proceed to list such security on the
Exchange. If the Index-Linked Security does not meet the continued
listing criteria, the staff of the Exchange would then, in its sole
discretion, either file a separate rule filing pursuant to Rule 19b-4
under the Act proposing that the Index-Linked Security be listed on the
Exchange pursuant to the criteria
[[Page 71074]]
set forth in the rule filing or decline to list the Index-Linked
Security on the Exchange.
Prior to listing on the Exchange, the issuer of a Derivative
Product would be required to properly delist from the Other SRO and
satisfy the applicable listing procedures of the Exchange and
applicable statutory and regulatory requirements, including, without
limitation, Section 12 of the Act,\5\ relating to listing such
Derivative Product on the Exchange. In addition, the Exchange
represents that, for any Derivative Product listed pursuant to proposed
Commentary .01 to NYSE Arca Equities Rule 5.2(b), other than the
initial listing standards, the shares or other units of such Derivative
Product will comply with all other pertinent requirements applicable to
the product class that would include such Derivative Product,
including, but not limited to, requirements relating to the
dissemination of key information, such as an index value, reference
asset value, and intraday indicative value, and rules governing the
trading of equity securities, trading hours, trading halts,
surveillance, firewalls, and Information Bulletins to ETP Holders, as
set forth in Exchange rules applicable to such Derivative Product and
prior Commission orders approving the generic listing rules applicable
to the listing and trading of such Derivative Product.
---------------------------------------------------------------------------
\5\ 15 U.S.C. 78(l).
---------------------------------------------------------------------------
III. Discussion and Commission's Findings
The Commission has carefully reviewed the proposed rule change and
finds that it is consistent with the requirements of Section 6 of the
Act \6\ and the rules and regulations thereunder applicable to a
national securities exchange.\7\ In particular, the Commission finds
that the proposed rule change is consistent with Section 6(b)(5) of the
Act,\8\ which requires, among other things, that the Exchange's rules
be designed to promote just and equitable principles of trade, to
remove impediments to and perfect the mechanism of a free and open
market and a national market system, and, in general, to protect
investors and the public interest.
---------------------------------------------------------------------------
\6\ 15 U.S.C. 78f.
\7\ In approving this proposed rule change, the Commission has
considered the proposed rule's impact on efficiency, competition,
and capital formation. See 15 U.S.C. 78c(f).
\8\ 15 U.S.C. 78f(b)(5).
---------------------------------------------------------------------------
The proposal would permit the Exchange to list and trade any
Derivative Product that (1) was originally listed on an Other SRO and
continues to be listed on such Other SRO, and (2) satisfies the
Exchange's continued listing criteria applicable to the product class
that would include such Derivative Product. The Commission believes
that the proposal reasonably balances the removal of impediments to a
free and open market with the protection of investors and the public
interest, two principles set forth in Section 6(b)(5) of the Act. The
Commission notes that (1) it has previously approved the generic
listing standards, including the continued listing criteria, applicable
to each product class that would include such Derivative Product, and
(2) the continued listing criteria applicable to a Derivative Product
are substantially similar to those of Other SROs that list such
Derivative Product.\9\ The Commission also notes that, for any
Derivative Product listed on the Exchange pursuant to proposed
Commentary .01 to NYSE Arca Equities Rule 5.2(b), the shares of such
Derivative Product must comply with all of the other pertinent
requirements applicable to the product class that would include such
Derivative Product including, without limitation, requirements relating
to the dissemination of key values and the rules governing the trading
of equity securities, trading hours, trading halts, surveillance,
firewalls, and Information Bulletins to ETP Holders, as set forth in
the applicable Exchange rules and prior Commission orders approving the
generic listing rules applicable to the listing and trading of such
Derivative Product. In addition, prior to listing on the Exchange, the
issuer of a Derivative Product must properly delist from the Other SRO
and satisfy all relevant Exchange listing procedures and applicable
statutory and regulatory requirements, including, without limitation,
Section 12 of the Act. If the Exchange seeks to list a Derivative
Product that does not satisfy the Exchange's continued listing
standards applicable to such product, it may not do so pursuant to
proposed Commentary .01 to NYSE Arca Equities Rule 5.2(b). Instead, the
Exchange must obtain prior Commission approval pursuant to Section
19(b)(2) of the Act.
---------------------------------------------------------------------------
\9\ For example, the following are NYSE Alternext US LLC (``NYSE
Alternext'') listing standards for Derivative Products having
similar or identical continued listing standards to those of the
Exchange: Index Fund Shares (NYSE Alternext Equities Rule 1000A et
seq.); Portfolio Depositary Receipts (Rules 1000 et seq.); Trust
Issued Receipts (Rules 1200 et seq.); and securities listed under
Section 107 of the NYSE Alternext Company Guide, including Equity-
Linked Term Notes; Index-Linked Exchangeable Notes; Index-Linked
Securities; Commodity-Linked Securities; Currency-Linked Securities;
Fixed Income-Linked Securities; Futures-Linked Securities; and
Combination-Linked Securities.
---------------------------------------------------------------------------
The Commission believes that the Exchange's proposal would
facilitate the timely and efficient listing and continuous trading of a
Derivative Product should an issuer of such Derivative Product,
originally listed on an Other SRO, choose to delist from such Other SRO
and list such Derivative Product on the Exchange, provided that all of
the requirements with respect to the Derivative Product referenced
herein, including all of the applicable requirements governing the
trading of such Derivative Product, as set forth in Exchange rules and
prior applicable Commission orders, are satisfied. For the foregoing
reasons, the Commission believes that the proposed rule change is
consistent with the Act and finds good cause for approving the proposed
rule change.
IV. Conclusion
It is therefore ordered, pursuant to Section 19(b)(2) of the
Act,\10\ that the proposed rule change (SR-NYSEArca-2008-105) be, and
it hereby is, approved.
---------------------------------------------------------------------------
\10\ 15 U.S.C. 78s(b)(1).
For the Commission, by the Division of Trading and Markets,
pursuant to delegated authority.\11\
---------------------------------------------------------------------------
\11\ 17 CFR 200.30-3(a)(12).
---------------------------------------------------------------------------
Florence E. Harmon,
Acting Secretary.
[FR Doc. E8-27878 Filed 11-21-08; 8:45 am]
BILLING CODE 8011-01-P